Integra LifeSciences begins cash tender offer for Derma Sciences acquisition: 5 notes

Spinal Tech

Integra Derma began a cash tender offer to acquire Princeton, N.J.-based Derma Sciences. Integra Derma is a wholly-owned subsidiary of Plainsboro, N.J.-based Integra LifeSciences.

Here are five notes:

 

1. The cash tender offer is to purchase all Derma Sciences' outstanding common and preferred shares.

 

2. Integra will purchase the shares at an offer price of $7 per share for the common stock; $32 per share for Derma Sciences' Series A Convertible Preferred Stock; and $48 per share for Derma Sciences' Series B Convertible Preferred Stock.

 

3. The tender offer is set to expire at midnight, Eastern Time, on Feb. 22, 2017.

 

4. The tender offer includes no financing condition.

 

5. The companies announced an agreement and plan to merge on Jan. 10, 2017.

 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.